WAY-262611 Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration. Product Specification Alternative Name: (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine Formula: C20H22N4 MW: 318.4 Purity: ≥97% (TLC) Appearance: Off-white solid. Solubility: Soluble in DMSO (30mg/ml) or in 100% ethanol (25mg/ml). Long Term Storage: -20°C Use/Stability: Stable for at least 6 months after receipt when stored at -20°C
